Susan M. Molineaux

Dr. Molineaux has served as the President, Chief Executive Officer, and a member of the board of directors since she co-founded Calithera in 2010. Prior to that, Dr. Molineaux co-founded Proteolix, a biopharmaceutical oncology company, where she served in various roles, including Chief Executive Officer, and Chief Scientific Officer until Proteolix’s acquisition by Onyx Pharmaceuticals. Prior to Proteolix, Dr. Molineaux served as Vice President of Biology at Rigel Pharmaceuticals and she began her biotech career at Praecis Pharmaceuticals. Dr. Molineaux began her career in drug discovery and development in the Immunology group at Merck. Dr. Molineaux currently serves as a member of the board of directors of Geron Corporation, Theravance Biopharma, Cyteir Therapeutics, and Smith College. Dr. Molineaux holds a B.S. in Biology from Smith College and a Ph.D. in Molecular Biology from Johns Hopkins University, and she completed a postdoctoral fellowship at Columbia University.